Insiders Updates
ESPR’s latest rating updates from top analysts.
In a filing, Esperion Therapeutics Inc revealed its General Counsel Looker Benjamin unloaded Company’s shares for reported $7398.0 on Jun
Menu
In a filing, Esperion Therapeutics Inc revealed its General Counsel Looker Benjamin unloaded Company’s shares for reported $7398.0 on Jun
Esperion Therapeutics Inc’s recently made public that its General Counsel Looker Benjamin unloaded Company’s shares for reported $7398.0 on Jun
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Esperion Therapeutics Inc’s recently made public that its Chief Commercial Officer Warren Eric unloaded Company’s shares for reported $106.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Esperion Therapeutics